Acupuncture may help improve perceived breast cancer-related cognitive difficulties over usual careAcupuncture may help improve perceived breast cancer-related cognitive difficulties over usual care
Real and sham acupuncture were more effective at improving breast cancer survivors’ perceived cognitive impairment compared with usual care, while real acupuncture was superior to sham acupuncture in improving objective cognitive function, according to results from the randomized ENHANCE Phase II clinical trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December 9–12, 2025.
Phase I trial finds breast cancer vaccine triggers an immune response and is safePhase I trial finds breast cancer vaccine triggers an immune response and is safe
Cleveland Clinic researchers are presenting final Phase I data from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.
Phase I trial finds breast cancer vaccine triggers an immune response and is safePhase I trial finds breast cancer vaccine triggers an immune response and is safe
Cleveland Clinic researchers are presenting final Phase I data from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.
Triple-negative breast cancer vaccine shows promise in early clinical trialTriple-negative breast cancer vaccine shows promise in early clinical trial
When Chase Johnson was 31, her dog began acting strange.
Triple-negative breast cancer vaccine shows promise in early clinical trialTriple-negative breast cancer vaccine shows promise in early clinical trial
When Chase Johnson was 31, her dog began acting strange.
Imaging study solves a long-standing gap in metastatic breast cancer research and careImaging study solves a long-standing gap in metastatic breast cancer research and care
A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated an improved method for predicting treatment benefits in patients with hormone receptor-positive (HR+) metastatic breast cancer that has spread primarily or exclusively to the bones.
Imaging study solves a long-standing gap in metastatic breast cancer research and careImaging study solves a long-standing gap in metastatic breast cancer research and care
A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated an improved method for predicting treatment benefits in patients with hormone receptor-positive (HR+) metastatic breast cancer that has spread primarily or exclusively to the bones.
GLP-1 Drugs Linked to Lower Epilepsy Risk in Diabetes PatientsGLP-1 Drugs Linked to Lower Epilepsy Risk in Diabetes Patients
(MedPage Today) — GLP-1 receptor agonists were tied to a lower risk of developing epilepsy in adults with type 2 diabetes, a large U.S. study showed. Compared with DPP-4 inhibitors, GLP-1 receptor agonist use was associated with a 16% lower risk… (MedPage Today) — GLP-1 receptor agonists were tied to a lower risk of Read More
ADC Post-Endocrine Therapy Misses Mark in Advanced Breast Cancer TrialADC Post-Endocrine Therapy Misses Mark in Advanced Breast Cancer Trial
(MedPage Today) — SAN ANTONIO — The antibody-drug conjugate (ADC) sacituzumab govitecan (Trodelvy) failed to outperform chemotherapy as first treatment after endocrine therapy for metastatic hormone receptor-positive/HER2-negative breast cancer…
Triplet Delays Breast Cancer Progression in First-Line Maintenance SettingTriplet Delays Breast Cancer Progression in First-Line Maintenance Setting
(MedPage Today) — SAN ANTONIO — Adding tucatinib (Tukysa) to first-line maintenance therapy with trastuzumab and pertuzumab (Perjeta) significantly improved progression-free survival (PFS) in patients with HER2-positive metastatic breast cancer…